The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer

作     者：Jeanny B Aragon-Ching Jeanny B Aragon-Ching

作者机构：GU Medical OncologyDepartment of OncologyInova Schar Cancer InstituteFairfaxVAUSA 

出 版 物：《Asian Journal of Andrology》 (亚洲男性学杂志（英文版）)

年 卷 期：2021年第23卷第1期

页      面：1-2页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：PSMA high finding 

摘      要：The proPSMA trial is a Phase III multicentric trial that examined the role of gallium-68-prostate-specific membrane an tigen(PSMA)-p o sitro n em issio n tomography/computed tomography(PET/CT)scan versus conventional CT and bone scan to determine the presence of distant disease prior to curative-intent treatment with surgery or radiation for men with highrisk prostate *** findings showed the superiority of PSMA PET/CT scan with 27%better accuracy and sensitivity at 92%versus conventional CT and bone scans.